<![CDATA[AOP Health 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=42247>Thu, 16 Apr 2026 21:50:08 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[AOP Health on Rare Diseases: Information. Collaboration. Innovation.]]>https://www.newswire.co.kr/newsRead.php?no=1029094Tue, 24 Feb 2026 10:15:00 +0900<![CDATA[AOP 헬스, 희귀질환에 대한 입장 발표… 정보·협력·혁신 강조]]>https://www.newswire.co.kr/newsRead.php?no=1029097Tue, 24 Feb 2026 10:15:00 +0900<![CDATA[Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH]]>https://www.newswire.co.kr/newsRead.php?no=1024953Tue, 09 Dec 2025 15:00:00 +0900<![CDATA[AOP 헬스, 혈액종양학 임상시험 결과 ASH 학회서 발표]]>https://www.newswire.co.kr/newsRead.php?no=1024954Tue, 09 Dec 2025 15:00:00 +0900<![CDATA[ICC Arbitral Tribunal Rules in Favor of AOP Health in Arbitration Proceedings Pertaining to BESREMi® (Ropeginterferon alfa-2b)]]>https://www.newswire.co.kr/newsRead.php?no=1006266Sun, 23 Feb 2025 13:20:00 +0900<![CDATA[ICC 중재 재판소, BESREMi® 관련 중재 절차에서 AOP 헬스에 승소 판결]]>https://www.newswire.co.kr/newsRead.php?no=1006267Sun, 23 Feb 2025 13:20:00 +0900<![CDATA[AOP Health: Completed Study Strengthens Clinical Development Program for ropeginterferon alpha 2b (Besremi®) in polycythaemia vera]]>https://www.newswire.co.kr/newsRead.php?no=968122Sun, 04 Jun 2023 10:20:00 +0900<![CDATA[AOP 헬스: 완료된 연구가 진성적혈구증가증에 대한 로페그인터페론알파 2b 임상 개발 프로그램을 강화]]>https://www.newswire.co.kr/newsRead.php?no=968123Sun, 04 Jun 2023 10:20:00 +0900<![CDATA[AOP Health congratulates FROM on its great scientific work in the field of myeloproliferative neoplasms]]>https://www.newswire.co.kr/newsRead.php?no=967003Tue, 16 May 2023 15:50:00 +0900<![CDATA[AOP 헬스, 골수증식성 신생물 분야에서 FROM의 과학적 업적 축하]]>https://www.newswire.co.kr/newsRead.php?no=967004Tue, 16 May 2023 15:50:00 +0900<![CDATA[AOP Health Presents New Findings Regarding Consistent Hematologic Response of Patients With polycythaemia vera]]>https://www.newswire.co.kr/newsRead.php?no=966857Sun, 14 May 2023 10:15:00 +0900<![CDATA[AOP 헬스, 진성적혈구증다증 환자의 일관된 혈액학적 반응에 대한 새 연구 결과 제시]]>https://www.newswire.co.kr/newsRead.php?no=966858Sun, 14 May 2023 10:15:00 +0900<![CDATA[AOP Health presents latest updates on BESREMi® (Ropeginterferon alfa-2b) in Polycythaemia Vera at the American Society of Hematology (ASH) 2022 Annual Meeting]]>https://www.newswire.co.kr/newsRead.php?no=957850Wed, 14 Dec 2022 10:00:00 +0900<![CDATA[AOP 헬스, 미국혈액학회 연례 회의서 전성적혈구증가증 치료제 ‘베스레미(로페그인터페론 알파-2b)’ 관련 최신 정보 공개]]>https://www.newswire.co.kr/newsRead.php?no=957851Wed, 14 Dec 2022 10:00:00 +0900